MPP+ toxicity and plasma membrane dopamine transporter:: study using cell lines expressing the wild-type and mutant rat dopamine transporters

被引:35
作者
Kitayama, S
Mitsuhata, C
Davis, S
Wang, JB
Sato, T
Morita, K
Uhl, GR
Dohi, T
机构
[1] Hiroshima Univ, Sch Dent, Dept Pharmacol, Minami Ku, Hiroshima 734, Japan
[2] NIDA, Mol Neurobiol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1998年 / 1404卷 / 03期
基金
美国国家卫生研究院;
关键词
dopamine; transporter; MPP+; Parkinsonism; neurotoxin; efflux;
D O I
10.1016/S0167-4889(98)00071-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium (MPP+) causes specific cell death in dopaminergic neurons after accumulation by the dopamine transporter (DAT). COS cells, a non-neuronal cell line insensitive to high doses of MPP+, becomes sensitive to MPP+ when transfected with the rat DAT cDNA. We analyzed the bi-directional transport of MPP+ and its toxicity in several cell lines expressing wild or mutant DATs. Cell death in COS cells expressing wild DAT by exposure to MPP+ was concentration-dependent and cocaine-reversible. Increased wild DAT expression caused higher sensitivities to the toxin in HeLa cells. Although several mutant DA'Ts demonstrated greater transport activity than the wildtype, they displayed similar or lower sensitivity to MPP+ toxicity. Reverse transport of preloaded [H-3]MPP+ through DAT was facilitated in COS cells expressing certain mutant DATs, which consistently displayed less sensitivity to MPP+ toxicity. These results suggest that re-distribution of MPP+ due to influx/efflux turnover through the transporter is a key factor in MPP+ toxicity. 0167-4889/98/$-see front matter (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 18 条
[1]   ACTIVE UPTAKE OF MPP+, A METABOLITE OF MPTP, BY BRAIN SYNAPTOSOMES [J].
CHIBA, K ;
TREVOR, AJ ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 128 (03) :1228-1232
[2]  
GIOVANNI A, 1994, J PHARMACOL EXP THER, V270, P1008
[3]  
GIOVANNI A, 1994, J PHARMACOL EXP THER, V270, P1000
[4]  
ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118, DOI 10.1248/cpb.41.1118
[5]   PARKINSONISM-INDUCING NEUROTOXIN, N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - UPTAKE OF THE METABOLITE N-METHYL-4-PHENYLPYRIDINE BY DOPAMINE NEURONS EXPLAINS SELECTIVE TOXICITY [J].
JAVITCH, JA ;
DAMATO, RJ ;
STRITTMATTER, SM ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (07) :2173-2177
[6]   Cellular and molecular aspects of monoamine neurotransmitter transporters [J].
Kitayama, S ;
Dohi, T .
JAPANESE JOURNAL OF PHARMACOLOGY, 1996, 72 (03) :195-208
[7]   Cocaine inhibits the release of MPP(+) but not dopamine through the rat dopamine transporter [J].
Kitayama, S ;
Morita, K ;
Dohi, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (01) :107-109
[8]   Uptake and release of dopamine through the rat dopamine transporter expressed in Xenopus laevis oocyte: Evaluation by voltammetric measurement of intracellular dopamine concentration [J].
Kitayama, S ;
Morita, K ;
Dohi, T .
NEUROSCIENCE LETTERS, 1996, 211 (02) :132-134
[9]   DOPAMINE TRANSPORTER MUTANTS SELECTIVELY ENHANCE MPP+ TRANSPORT [J].
KITAYAMA, S ;
WANG, JB ;
UHL, GR .
SYNAPSE, 1993, 15 (01) :58-62
[10]   DOPAMINE TRANSPORTER SITE-DIRECTED MUTATIONS DIFFERENTIALLY ALTER SUBSTRATE TRANSPORT AND COCAINE BINDING [J].
KITAYAMA, S ;
SHIMADA, S ;
XU, HX ;
MARKHAM, L ;
DONOVAN, DM ;
UHL, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7782-7785